US Patent Issued to MINERVA BIOTECHNOLOGIES on Sept. 16 for "Anti-NME antibody and method of treating cancer or cancer metastasis" (Hawaii, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,868, issued on Sept. 16, was assigned to MINERVA BIOTECHNOLOGIES Corp. (Waltham, Mass.).

"Anti-NME antibody and method of treating cancer or cancer metastasis" was invented by Cynthia Bamdad (Boston) and Benoit Smagghe (Honolulu).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses anti-NMR antibodies and their use in treating or preventing diseases."

The patent was filed on Sept. 20, 2024, under Application No. 18/892,093.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&...